Quodria Ltd
Home
Indications
  • Atopic Dermatitis
  • Psoriasis
PROJECTS
  • Q001
  • Q002
  • Q003
  • Base formulation
Our Team
Quodria News
Investment
Contact us
Quodria Ltd
Home
Indications
  • Atopic Dermatitis
  • Psoriasis
PROJECTS
  • Q001
  • Q002
  • Q003
  • Base formulation
Our Team
Quodria News
Investment
Contact us
More
  • Home
  • Indications
    • Atopic Dermatitis
    • Psoriasis
  • PROJECTS
    • Q001
    • Q002
    • Q003
    • Base formulation
  • Our Team
  • Quodria News
  • Investment
  • Contact us

  • Home
  • Indications
    • Atopic Dermatitis
    • Psoriasis
  • PROJECTS
    • Q001
    • Q002
    • Q003
    • Base formulation
  • Our Team
  • Quodria News
  • Investment
  • Contact us

Q003: A NEW FIRST-IN-CLASS TOPICAL TREATMENT FOR PSORIASIS

Q003 is a non-steroidal topical therapy designed for use either as a standalone treatment or in combination with other approaches for managing psoriasis. It employs the same galectin-3 targeting mechanism established in Q001. Formulated as a light cream, Q003 contains active ingredients that enhance skin hydration and help alleviate inflammation, supporting both symptom relief and skin barrier restoration.

Copyright © 2025 Quodria Ltd - All Rights Reserved.

Powered by

  • Investment
  • Contact us
  • Privacy Policy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept